Skip to main content


Page 4 of 33

  1. Some major challenges of ovarian tissue vitrification and transplantation include follicle apoptosis induced by cryopreservation and ischemia-reperfusion injury, as well as ovarian follicle loss during post-tr...

    Authors: Fei Wang, Yuan Tian, Liwen Huang, Tian Qin, Wenye Ma, Chengbin Pei, Bo Xu, Hang Han, Xinrui Liu, Pengge Pan, Xiaoli Yu, Qin Chang, Yanrong Wang, Shuya Zhang and Xiuying Pei
    Citation: Journal of Ovarian Research 2023 16:173
  2. Explore the therapeutic role of human umbilical mesenchymal stem cells (hUMSCs) transplantation for regeneration of ECM components and restoration of follicular development in mice.

    Authors: Yin Shuyuan, Wang Meimei, Li Fenghua, Zhao Huishan, Chu Min, Bao Hongchu and Liu Xuemei
    Citation: Journal of Ovarian Research 2023 16:172
  3. The functions and molecular mechanisms of long noncoding RNA (lncRNA) in reproduction have been widely studied at present. However, lncRNA regulating hormone synthesis in ovarian follicular granulosa cells has...

    Authors: Ke Hu, Chen Wang, Yifan Xu, Fan Li, Xuefeng Han, Chuanwang Song and Meng Liang
    Citation: Journal of Ovarian Research 2023 16:171

    The Correction to this article has been published in Journal of Ovarian Research 2023 16:199

  4. Infertility is one of the common problems among couples, affecting millions of people worldwide. Polycystic ovary syndrome (PCOS) is one of the main causes of infertility in women and is associated with abnorm...

    Authors: Ali Sarhadi Roodbari, Somayeh Solhjoo, Maria Grazia Palmerini, Mahna Mansouri and Massood Ezzatabadipour
    Citation: Journal of Ovarian Research 2023 16:170
  5. Ovarian cancer (OC) is one of the most common gynecologic malignant cancers with the current survival rate remaining low. TRPM2 has been reported as a survival predictor in various cancers but not in OC. The a...

    Authors: Wei Huang, Yuliang Wu, Ning Luo, Xueqian Shuai, Jing Guo, Chunyan Wang, Fanchun Yang, Li Liu, Shupeng Liu and Zhongping Cheng
    Citation: Journal of Ovarian Research 2023 16:169
  6. In 2023, the final PAOLA-1 trial (NCT02477644) survival data were published documenting the benefits of therapy consisting of olaparib plus bevacizumab for patients with advanced ovarian cancer (AOC) as a func...

    Authors: Youwen Zhu, Kun Liu, Hui Cao and Hong Zhu
    Citation: Journal of Ovarian Research 2023 16:168
  7. Polycystic ovary syndrome (PCOS) is characterized by insulin resistance and hormonal disorder in women. This study aimed to assess the effect of maternal PCOS on screening of aneuploidy in the first and second...

    Authors: Narjes Hassan Haivadi, Shahideh Jahanian Sadatmahalleh, Fatemeh Razavinia, Sarang Younesi, Malihe Nasiri and Saeideh Ziaei
    Citation: Journal of Ovarian Research 2023 16:167
  8. Although n-hexane can induce ovarian damage by inducing ovarian granulosa cell (GC) apoptosis, the mechanism underlying this induction of apoptosis has not been fully elucidated. In this study, rat ovarian GCs...

    Authors: Yi Sun, Huiting Chen, Sichuan Chen, Xueming Xu, Wenchang Zhang and Yuchen Li
    Citation: Journal of Ovarian Research 2023 16:161
  9. Fanconi anemia (FA) gene mutations are critical components in the genetic etiology of premature ovarian insufficiency (POI). Fance−/− mice detected meiotic arrest of primordial germ cells (PGCs) as early as embry...

    Authors: Zhixian Zhou, Huan Yin, Suye Suye, Zhen Ren, Lei Yan, Liye Shi and Chun Fu
    Citation: Journal of Ovarian Research 2023 16:160
  10. The indications for fertility preservation (FP) have expanded. A few patients who underwent gonadotoxic treatment did not have the opportunity to receive FP, leading to concerns that these patients may develop...

    Authors: Saki Saito, Mitsutoshi Yamada, Rika Yano, Kazuko Takahashi, Akiko Ebara, Hiroe Sakanaka, Miho Matsumoto, Tomoko Ishimaru, Hiroki Utsuno, Yuichi Matsuzawa, Reina Ooka, Mio Fukuoka, Kazuhiro Akashi, Shintaro Kamijo, Toshio Hamatani and Mamoru Tanaka
    Citation: Journal of Ovarian Research 2023 16:159
  11. Polycystic ovarian syndrome (PCOS) is a disorder with a foundation of neuroendocrine dysfunction, characterized by increased gonadotropin-releasing hormone (GnRH) pulsatility, which is antagonized by dopamine....

    Authors: Mutaz Amin, Nicholas Horst and Claudia Gragnoli
    Citation: Journal of Ovarian Research 2023 16:158
  12. Bi-directional communication between cumulus cells and the surrounded oocytes is important for the development and functions of both compartments. However, the metabolic framework in cumulus cells has not been...

    Authors: Ming Chen, Weizheng Yang, Yueshuai Guo, Xiaojing Hou, Shuai Zhu, Hongzheng Sun, Xuejiang Guo, Minjian Chen and Qiang Wang
    Citation: Journal of Ovarian Research 2023 16:156
  13. Women with polycystic ovarian syndrome (PCOS) have increased hypothalamic–pituitary–adrenal (HPA) axis activation, pro-inflammatory mediators, and psychological distress in response to stressors. In women with...

    Authors: Mutaz Amin, Nicholas Horst, Rongling Wu and Claudia Gragnoli
    Citation: Journal of Ovarian Research 2023 16:155
  14. Polycystic ovary syndrome (PCOS) is a common reproductive, neuroendocrine, and metabolic disorder in women of reproductive age that affects up to 5–10% of women of reproductive age. The aetiology of follicle d...

    Authors: Qingfang Li, Yimiao Sang, Qingqing Chen, Bingru Ye, Xiaoqian Zhou and Yimin Zhu
    Citation: Journal of Ovarian Research 2023 16:154
  15. Sclerosing stromal tumors of the ovary are benign and tend to occur in youthful women with lobular structures at low frequencies. Three types of cells, including luteinized cells, short spindle myoid cells, an...

    Authors: Li Zhao, Zhongfeng Yang, Yan Zhou, Yuping Liu, Qiuping Luo, Qingping Jiang, Hui Wang and Na Wang
    Citation: Journal of Ovarian Research 2023 16:152
  16. Excessive production of androgen drives oxidative stress (OS) and inflammasome activation in ovarian granulosa cells (GCs). Therefore, the induced follicular developmental disorder is the major cause of infert...

    Authors: Yajing Weng, Yaling Zhang, Daojuan Wang, Rong Wang, Zou Xiang, Shanmei Shen, Hongwei Wang, Xiaoke Wu, Yanting Wen and Yong Wang
    Citation: Journal of Ovarian Research 2023 16:151
  17. Mechanisms of development and progression of high-grade serous ovarian cancer (HGSOC) are poorly understood. EVI1 and PARP1, part of TGF-ß pathway, are upregulated in cancers with DNA repair deficiencies with ...

    Authors: Paul Jank, Jonas Leichsenring, Svenja Kolb, Inga Hoffmann, Philip Bischoff, Catarina Alisa Kunze, Mihnea P. Dragomir, Moritz Gleitsmann, Moritz Jesinghaus, Wolfgang D. Schmitt, Hagen Kulbe, Christine Sers, Albrecht Stenzinger, Jalid Sehouli, Ioana Elena Braicu, Christina Westhoff…
    Citation: Journal of Ovarian Research 2023 16:150
  18. Polycystic ovary syndrome (PCOS) is known as a prevalent but complicated gynecologic disease throughout the reproductive period. Typically, it is characterized by phenotypic manifestations of hyperandrogenism,...

    Authors: Yuli Geng, Zhuo Liu, Runan Hu, Wenwen Ma, Xiao Wu, Haoxu Dong, Kunkun Song, Xiaohu Xu, Yanjing Huang, Fan Li, Yufan Song and Mingmin Zhang
    Citation: Journal of Ovarian Research 2023 16:149
  19. Over the past two decades, increasing number of people with cystic fibrosis (CF) survive into adulthood. Compared to the general population, sub-fertility is an obstacle for many women with CF (wwCF). Decrease...

    Authors: Malena Cohen-Cymberknoh, Keren Marks Garber, Joel Reiter, Michal Shteinberg, Aielet Stolovas, Iyad Barghouti, Chana Adler Lazarovits, Efrat Esh Broder and Anat Hershko Klement
    Citation: Journal of Ovarian Research 2023 16:148
  20. A recent study reported the role of long non-coding RNA (lncRNA) RBAT1 in promoting the development of retinoblastoma and bladder cancer. However, its function in other cancers is unclear. We then studied the ...

    Authors: Lingye Fan, Chunyan Wang, Ping Zhan and Yaofang Liu
    Citation: Journal of Ovarian Research 2023 16:147
  21. To establish an early clinical diagnosis model based on the retinal vascular features associated with POI, supplying a non-invasive way for accurately and early predicted the risk of POI.

    Authors: Jiaman Wu, Liya Tan, Yan Ning, Weiqu Yuan, Zuowei Lee, Fei Ma, Erfeng Wang and Yuanyuan Zhuo
    Citation: Journal of Ovarian Research 2023 16:146
  22. Granulosa cells (GCs) that surround oocytes in mammalian reproduction play an active role in oocyte differentiation through proliferation and energy production.

    Authors: Ya-Kun Zhao, Ya-Na Gao, Ling-Chao Wang, Jing Wang, Gai-Jing Wang and Hong-Li Wu
    Citation: Journal of Ovarian Research 2023 16:145
  23. The current study attempted to investigate the role of transcription factor c-fos in the development of premature ovarian insufficiency (POI) as well as the underlying mechanism involving the MALAT1/miR-22-3p/...

    Authors: Ting Qiu, Jie Zhou, Bing Ji, Liuyang Yuan, Tingsong Weng and Huishu Liu
    Citation: Journal of Ovarian Research 2023 16:144
  24. To explore the effect of intervention programs constructed under the guidance of the comprehensive unit-based safety program (CUSP) model on chemotherapy-induced nausea and vomiting (CINV) in patients with ova...

    Authors: Aihua Liu, Min Li, Zhuo Liu, Xinxin Xie, Wen Yao, Jingmin Wang, Tingting Zhao and Jie Yang
    Citation: Journal of Ovarian Research 2023 16:143
  25. Accumulating studies have reported indispensable functions of circular RNAs (circRNA) in tumor progression through regulation of gene expression. However, circRNA expression profiles and functions in human ova...

    Authors: Hongxia Wang, Suwei Lan, Lingxiang Wang, Jingyun Zhao, Xinzhuan Jia, Jie Xu, Guangyu Sun, Leilei Liu, Shan Gong, Na Wang, Baoen Shan, Fenghua Zhang and Zhengmao Zhang
    Citation: Journal of Ovarian Research 2023 16:142
  26. High-grade serous ovarian cancers (HGSCs) display a high degree of complex genetic alterations. In this study, we identified germline and somatic genetic alterations in HGSC and their association with relapse-...

    Authors: A. W. Adamson, Y. C. Ding, L. Steele, L. A. Leong, R. Morgan, M. T. Wakabayashi, E. S. Han, T. H. Dellinger, P. S. Lin, A. A. Hakim, S. Wilczynski, C. D. Warden, S. Tao, V. Bedell, M. C. Cristea and S. L. Neuhausen
    Citation: Journal of Ovarian Research 2023 16:141
  27. Thyroid autoimmunity and polycystic ovary syndrome (PCOS) are the most common endocrinopathies and have close relationships based on common etiology and pathogenesis, including genetic susceptibility, metaboli...

    Authors: Huahua Jiang, Lixue Chen, Ning Huang, Huifeng Shi, Hongbin Chi, Rui Yang, Xiaoyu Long and Jie Qiao
    Citation: Journal of Ovarian Research 2023 16:140
  28. The specific long-term trend in ovarian cancer (OC) rates in China has been rarely investigated. We aimed to estimate the temporal trends in incidence and mortality rates from 1990 to 2019 in OC and predict th...

    Authors: Jianyang Feng, Lijiang Xu, Yangping Chen, Rongjin Lin, Haoxian Li and Hong He
    Citation: Journal of Ovarian Research 2023 16:139
  29. Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder that frequently exhibits low-grade inflammation, pro-oxidant activity, and gut dysbiosis. PCOS has become one of the leading causes ...

    Authors: Hong Zhang, Lu Zheng, Chuwei Li, Jun Jing, Zhou Li, Shanshan Sun, Tongmin Xue, Kemei Zhang, Mengqi Xue, Chun Cao, Lei Ouyang, Zhang Qian, Rui Xu, Zhaowanyue He, Rujun Ma, Li Chen…
    Citation: Journal of Ovarian Research 2023 16:138
  30. Folliculogenesis is a complex network of interacting cellular signals between somatic cells and oocytes. Many components in ovarian follicular fluid (FF) dynamically change during folliculogenesis and play a p...

    Authors: Jia Liu and Chong Wang
    Citation: Journal of Ovarian Research 2023 16:137
  31. Paclitaxel dose-dense regimen has been controversial in clinical trials in recent years. This systematic review and meta-analysis tried to evaluate the efficacy and safety of paclitaxel dose-dense chemotherapy...

    Authors: Wenjian Gong, Ruidi Yu, Canhui Cao, Yong Fang, Xuejiao Zhao and Qinglei Gao
    Citation: Journal of Ovarian Research 2023 16:136
  32. Premature ovarian insufficiency (POI) is a clinically heterogeneous disease that may seriously affect the physical and mental health of women of reproductive age. POI primarily manifests as ovarian function de...

    Authors: Xuechun Ding, Xiaowei Gong, Yingying Fan, Jinghe Cao, Jingyu Zhao, Yixin Zhang, Xiaomei Wang and Kai Meng
    Citation: Journal of Ovarian Research 2023 16:135
  33. Cangfu Daotan Wan (CFDTW) has been widely used for polycystic ovary syndrome (PCOS) patients in the type of stagnation of phlegm and dampness. In this study, we aimed to evaluate the mechanism underlying the t...

    Authors: Yuan Li, Haicui Wu, Ying Guo, Chaofeng Wei, Lu Guan, Wenhan Ju and Fang Lian
    Citation: Journal of Ovarian Research 2023 16:134
  34. Multiple-organ primary tumors can invade the ovary through lymphatic and hematogenous routes, presenting as ovarian Krukenberg tumors, but these rarely originate from the gallbladder. Krukenberg tumors can pre...

    Authors: Jing Wang, Yanjun Liu, Liang Sang and Weina Wan
    Citation: Journal of Ovarian Research 2023 16:133
  35. When prepubertal lambs are superovulated, the ovarian response to gonadotropin stimulation has great individual difference and the collected oocytes have lower developmental ability than that of adult ewes. Ov...

    Authors: Kexiong Liu, Luyao Zhang, Qi Qi, Junjin Li, Fengxiang Yan and Jian Hou
    Citation: Journal of Ovarian Research 2023 16:132
  36. Telomeres are repetitive DNA sequences at eukaryotic chromosome ends and function in maintaining genome integrity and stability. These unique structures undergo shortening due to various factors including biol...

    Authors: Betul Tire and Saffet Ozturk
    Citation: Journal of Ovarian Research 2023 16:130
  37. Endometrial carcinoma (EC) is the sixth most frequent malignancy in women and is often linked to high estrogen exposure. Polycystic ovarian syndrome (PCOS) is a known risk factor for EC, but the underlying mec...

    Authors: Yun Zhang, Yifang Hu, Jian Yu, Xiaoyan Xie, Feng Jiang and Chuyan Wu
    Citation: Journal of Ovarian Research 2023 16:129
  38. Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder in women of reproductive age that still lacks effective treatment. Inflammation is one of the important features of PCOS. Asparagus ...

    Authors: Jinshan Xing, Xin Luo, Keran Jia, Shuang Liu, Shaokun Chen, Gan Qiao, Chunxiang Zhang and Jingyan Yi
    Citation: Journal of Ovarian Research 2023 16:128
  39. Advanced glycation end products (AGEs) are known to associate with the pathogenesis of several chronic diseases via interaction with their corresponding receptor (RAGE). The soluble forms of RAGE (sRAGE) are c...

    Authors: Neda Emami, AliReza Alizadeh, Arezoo Maleki-Hajiagha, Alireza Dizavi, Samira Vesali and Ashraf Moini
    Citation: Journal of Ovarian Research 2023 16:127
  40. Risk-reducing salpingo-oophorectomy (RRSO) is recommended for women at increased risk of breast and ovarian cancer. We launched a prospective study of women receiving RRSO, including those with mutations in ge...

    Authors: Zheng Feng, Ke Zuo, Xingzhu Ju, Xiaojun Chen, Wentao Yang, Hao Wen, Lin Yu and Xiaohua Wu
    Citation: Journal of Ovarian Research 2023 16:125
  41. MicroRNAs are a group of small non-coding RNAs that are involved in development and diseases such as cancer. Previously, we demonstrated that miR-335 is crucial for preventing collagen type XI alpha 1 (COL11A1...

    Authors: Yi-Hui Wu, Yu-Fang Huang, Pei-Ying Wu, Tzu-Hao Chang, Soon-Cen Huang and Cheng-Yang Chou
    Citation: Journal of Ovarian Research 2023 16:124

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.